Literature DB >> 25019562

Multi-ethnic study of atherosclerosis: association between left atrial function using tissue tracking from cine MR imaging and myocardial fibrosis.

Masamichi Imai1, Bharath Ambale Venkatesh, Sanaz Samiei, Sirisha Donekal, Mohammadali Habibi, Anderson C Armstrong, Susan R Heckbert, Colin O Wu, David A Bluemke, João A C Lima.   

Abstract

PURPOSE: To investigate the association between left atrial ( LA left atrium ) function and left ventricular myocardial fibrosis using cardiac magnetic resonance (MR) imaging in a multi-ethnic population.
MATERIALS AND METHODS: For this HIPAA-compliant study, the institutional review board at each participating center approved the study protocol, and all participants provided informed consent. Of 2839 participants who had undergone cardiac MR in 2010-2012, 143 participants with myocardial scar determined with late gadolinium enhancement and 286 age-, sex-, and ethnicity-matched control participants were identified. LA left atrium volume, strain, and strain rate were analyzed by using multimodality tissue tracking from cine MR imaging. T1 mapping was applied to assess diffuse myocardial fibrosis. The association between LA left atrium parameters and myocardial fibrosis was evaluated with the Student t test and multivariable regression analysis.
RESULTS: The scar group had significantly higher minimum LA left atrium volume than the control group (mean, 22.0 ± 10.5 [standard deviation] vs 19.0 ± 7.8, P = .002) and lower LA left atrium ejection fraction (45.9 ± 10.7 vs 51.3 ± 8.7, P < .001), maximal LA left atrium strain ( Smax maximum LA strain ) (25.4 ± 10.7 vs 30.6 ± 10.6, P < .001) and maximum LA left atrium strain rate ( SRmax maximum LA strain rate ) (1.08 ± 0.45 vs 1.29 ± 0.51, P < .001), and lower absolute LA left atrium strain rate at early diastolic peak ( SRE LA strain rate at early diastolic peak ) (-0.77 ± 0.42 vs -1.01 ± 0.48, P < .001) and LA left atrium strain rate at atrial contraction peak ( SRA LA strain rate at atrial contraction peak ) (-1.50 ± 0.62 vs -1.78 ± 0.69, P < .001) than the control group. T1 time 12 minutes after contrast material injection was significantly associated with Smax maximum LA strain (β coefficient = 0.043, P = .013), SRmax maximum LA strain rate (β coefficient = 0.0025, P = .001), SRE LA strain rate at early diastolic peak (β coefficient = -0.0016, P = .027), and SRA LA strain rate at atrial contraction peak LA strain rate at atrial contraction peak (β coefficient -0.0028, P = .01) in the regression model. T1 time 25 minutes after contrast material injection was significantly associated with SRmax maximum LA strain rate (β coefficient = 0.0019, P = .016) and SRA LA strain rate at atrial contraction peak (β coefficient = -0.0022, P = .034).
CONCLUSION: Reduced LA left atrium regional and global function are related to both replacement and diffuse myocardial fibrosis processes. Clinical trial registration no.: NCT00005487 © RSNA, 2014 Online supplemental material is available for this article.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25019562      PMCID: PMC4314120          DOI: 10.1148/radiol.14131971

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  33 in total

1.  Left atrial enlargement and NT-proBNP as predictors of sudden cardiac death in patients with heart failure.

Authors:  Antoni Bayes-Genis; Rafael Vazquez; Teresa Puig; Carlos Fernandez-Palomeque; Jordi Fabregat; Alfredo Bardají; Domingo Pascual-Figal; Jordi Ordoñez-Llanos; Mariano Valdes; Albert Gabarrús; Ricardo Pavon; Luis Pastor; Jose Ramon Gonzalez Juanatey; Jesus Almendral; Miquel Fiol; Vicente Nieto; Carlos Macaya; Juan Cinca; Antoni Bayes de Luna
Journal:  Eur J Heart Fail       Date:  2007-06-13       Impact factor: 15.534

2.  Two-dimensional echocardiographic methods for assessment of left atrial volume.

Authors:  Keiji Ujino; Marion E Barnes; Stephen S Cha; Andrew P Langins; Kent R Bailey; James B Seward; Teresa S M Tsang
Journal:  Am J Cardiol       Date:  2006-09-07       Impact factor: 2.778

Review 3.  Left atrial size: physiologic determinants and clinical applications.

Authors:  Walter P Abhayaratna; James B Seward; Christopher P Appleton; Pamela S Douglas; Jae K Oh; A Jamil Tajik; Teresa S M Tsang
Journal:  J Am Coll Cardiol       Date:  2006-06-20       Impact factor: 24.094

4.  Left ventricular mass and ventricular remodeling among Hispanic subgroups compared with non-Hispanic blacks and whites: MESA (Multi-ethnic Study of Atherosclerosis).

Authors:  Carlos J Rodriguez; Ana V Diez-Roux; Andrew Moran; Zhezhen Jin; Richard A Kronmal; Joao Lima; Shunichi Homma; David A Bluemke; R Graham Barr
Journal:  J Am Coll Cardiol       Date:  2010-01-19       Impact factor: 24.094

5.  Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.

Authors:  Andrew S Flett; Martin P Hayward; Michael T Ashworth; Michael S Hansen; Andrew M Taylor; Perry M Elliott; Christopher McGregor; James C Moon
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

6.  Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis.

Authors:  Kan N Hor; William M Gottliebson; Christopher Carson; Erin Wash; James Cnota; Robert Fleck; Janaka Wansapura; Piotr Klimeczek; Hussein R Al-Khalidi; Eugene S Chung; D Woodrow Benson; Wojciech Mazur
Journal:  JACC Cardiovasc Imaging       Date:  2010-02

7.  Usefulness of radial strain mapping by multidetector computer tomography to quantify regional myocardial function in patients with healed myocardial infarction.

Authors:  Thomas M Helle-Valle; Wen-Chung Yu; Verônica R S Fernandes; Boaz D Rosen; João A C Lima
Journal:  Am J Cardiol       Date:  2010-08-15       Impact factor: 2.778

Review 8.  Independent relationship of left atrial size and mortality in patients with heart failure: an individual patient meta-analysis of longitudinal data (MeRGE Heart Failure).

Authors:  Andrea Rossi; Pier Luigi Temporelli; Miguel Quintana; Frank L Dini; Stefano Ghio; Graham S Hillis; Allan L Klein; Nina Ajmone Marsan; David L Prior; Cheuk Man Yu; Katrina K Poppe; Robert N Doughty; Gillian A Whalley
Journal:  Eur J Heart Fail       Date:  2009-10       Impact factor: 15.534

9.  A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging.

Authors:  Kristopher W Cummings; Sanjeev Bhalla; Cylen Javidan-Nejad; Andrew J Bierhals; Fernando R Gutierrez; Pamela K Woodard
Journal:  Radiographics       Date:  2009 Jan-Feb       Impact factor: 5.333

10.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.

Authors:  Leah Iles; Heinz Pfluger; Arintaya Phrommintikul; Joshi Cherayath; Pelin Aksit; Sandeep N Gupta; David M Kaye; Andrew J Taylor
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

View more
  29 in total

1.  Left Atrial Phasic Function by Cardiac Magnetic Resonance Feature Tracking Is a Strong Predictor of Incident Cardiovascular Events.

Authors:  Julio A Chirinos; Mayank Sardana; Bilal Ansari; Vaibhav Satija; Daniel Kuriakose; Ilaina Edelstein; Garrett Oldland; Rachana Miller; Swetha Gaddam; Jonathan Lee; Arpita Suri; Scott R Akers
Journal:  Circ Cardiovasc Imaging       Date:  2018-12       Impact factor: 7.792

2.  Left atrial physiology and pathophysiology: Role of deformation imaging.

Authors:  Johannes Tammo Kowallick; Joachim Lotz; Gerd Hasenfuß; Andreas Schuster
Journal:  World J Cardiol       Date:  2015-06-26

3.  Impaired left atrial function predicts inappropriate shocks in primary prevention implantable cardioverter-defibrillator candidates.

Authors:  Susumu Tao; Hiroshi Ashikaga; Luisa A Ciuffo; Kihei Yoneyama; Joao A C Lima; Terry F Frank; Robert G Weiss; Gordon F Tomaselli; Katherine C Wu
Journal:  J Cardiovasc Electrophysiol       Date:  2017-06-22

Review 4.  Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy.

Authors:  Chike C Nwabuo; Ramachandran S Vasan
Journal:  Curr Hypertens Rep       Date:  2020-02-03       Impact factor: 5.369

Review 5.  Cardiac MRI: a central prognostic tool in myocardial fibrosis.

Authors:  Bharath Ambale-Venkatesh; João A C Lima
Journal:  Nat Rev Cardiol       Date:  2014-10-28       Impact factor: 32.419

6.  Early detection of left atrial dysfunction assessed by CMR feature tracking in hypertensive patients.

Authors:  Lu Li; Xiuyu Chen; Gang Yin; Weipeng Yan; Chen Cui; Huaibin Cheng; Minjie Lu; Shihua Zhao
Journal:  Eur Radiol       Date:  2019-09-12       Impact factor: 5.315

7.  Association of myocardial fibrosis and cardiovascular events: the multi-ethnic study of atherosclerosis.

Authors:  Bharath Ambale-Venkatesh; Chia-Ying Liu; Yuan-Chang Liu; Sirisha Donekal; Yoshiaki Ohyama; Ravi K Sharma; Colin O Wu; Wendy S Post; Gregory W Hundley; David A Bluemke; João A C Lima
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-02-01       Impact factor: 6.875

8.  Association of left atrial function and left atrial enhancement in patients with atrial fibrillation: cardiac magnetic resonance study.

Authors:  Mohammadali Habibi; Joao A C Lima; Irfan M Khurram; Stefan L Zimmerman; Vadim Zipunnikov; Kotaro Fukumoto; David Spragg; Hiroshi Ashikaga; John Rickard; Joseph E Marine; Hugh Calkins; Saman Nazarian
Journal:  Circ Cardiovasc Imaging       Date:  2015-02       Impact factor: 7.792

9.  Quantifying left atrial structure and function using single-plane tissue-tracking cardiac magnetic resonance.

Authors:  Susumu Tao; Luisa A Ciuffo; Joao A C Lima; Katherine C Wu; Hiroshi Ashikaga
Journal:  Magn Reson Imaging       Date:  2017-06-19       Impact factor: 2.546

10.  Association of left atrial structure and function and incident cardiovascular disease in patients with diabetes mellitus: results from multi-ethnic study of atherosclerosis (MESA).

Authors:  Timothy M Markman; Mohammadali Habibi; Bharath Ambale Venkatesh; Mytra Zareian; Colin Wu; Susan R Heckbert; David A Bluemke; Joao A C Lima
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2017-10-01       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.